This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Marie Meyer: Innovator in Pharmaceutical Composition
Introduction
Marie Meyer is a notable inventor based in Hésingue, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that address various medical conditions.
Latest Patents
Marie Meyer holds a patent for the crystalline form of LNP023. This patent describes a crystalline hydrate form of LNP023 hydrochloride and outlines a process for its preparation. Additionally, it details a pharmaceutical composition that includes the crystalline hydrate form of LNP023 hydrochloride, along with at least one pharmaceutically acceptable excipient. This composition is designed to treat diseases and disorders mediated by complement activation.
Career Highlights
Marie Meyer is associated with Novartis AG, a leading global healthcare company. Her work focuses on advancing pharmaceutical innovations that can improve patient outcomes and enhance therapeutic options.
Collaborations
Marie has collaborated with esteemed colleagues such as Zichen Jia and Philipp Lustenberger, contributing to the advancement of her research and the development of new pharmaceutical solutions.
Conclusion
Marie Meyer exemplifies the spirit of innovation in the pharmaceutical industry through her groundbreaking work on LNP023. Her contributions are poised to make a significant impact on the treatment of diseases related to complement activation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile